{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-095869","form_type":"8-K","ticker":"KMTS","cik":"0001877184","company_name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","filed_at":"2025-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.481227+00:00","generated_at":"2026-05-18T06:32:25.086856+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Kestra Medical Q4 rev $17.2M (+71%), FY rev $59.8M (+115%); guides FY26 $85M","bullets":["Q4 revenue $17.2M (+71% YoY); FY25 revenue $59.8M (+115% YoY).","Q4 gross margin 44.3% vs 13.9% prior year; FY gross margin 40.5% vs 1.3%.","Q4 prescriptions: 3,903 (+43% YoY); FY prescriptions: 13,193 (+72% YoY).","FY26 revenue guidance initiated at $85M, representing 42% growth over FY25.","GAAP net loss $51.1M in Q4; adjusted EBITDA loss $20.3M; cash $237.6M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-095869","json":"https://secwatch.observer/filing/0000950170-25-095869.json","markdown":"https://secwatch.observer/filing/0000950170-25-095869.md","text":"https://secwatch.observer/filing/0000950170-25-095869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025095869/0000950170-25-095869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025095869/ck0001877184-20250715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:32:25.086856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}